SECsense Logo

Intelligent Bio Solutions Inc. 10-K/A Report: Key Amendments & Financial Insights

$INBS
Form 10-K/A
Filed on: 2025-02-13
Source
Intelligent Bio Solutions Inc. 10-K/A Report: Key Amendments & Financial Insights

Here are the key insights extracted from the provided financial report section:

  1. Company Identification:
  • Name: Intelligent Bio Solutions Inc.
  • CIK Number: 0001725430
  • Address: 135 West, 41st Street, 5th Floor, New York, NY 10036
  • Phone: 646-828-8258
  • Ticker Symbol: INBS
  • Exchange: NASDAQ
  1. Filing Information:
  • Filing Type: Amendment No. 1 on Form 10-K/A
  • Original Form 10-K Filing Date: September 18, 2024
  • Fiscal Year Ended: June 30, 2024
  • Filing Purpose: To update auditor’s consent and cover page of the original Form 10-K.
  1. Changes in the Amendment:
  • The amendment updates Exhibit 23.1 (auditor's consent) to include the Registration Statement on Form S-1 (File No. 333-273219).
  • The cover page now indicates that no documents are incorporated by reference.
  • Updates include currently dated certifications from the Company’s principal executive officer and principal financial officer as required under Section 302 of the Sarbanes-Oxley Act of 2002.
  1. Financial Impact:
  • The amendment does not change or update the Company’s consolidated financial statements or any other disclosures from the original Form 10-K.
  • The amendment is strictly limited to the updates outlined and does not reflect any subsequent events or information post the original filing date.
  1. Audit Information:
  • The Company utilizes UHY LLP as its auditors, based in Melville, NY.
  1. Regulatory Status:
  • The Company is classified as a non-accelerated filer.
  1. Financial Reporting Context:
  • The periods referenced include a fiscal year from July 1, 2023, to June 30, 2024, and instant contexts as of December 31, 2023, and September 16, 2024.
  1. Important Units of Measure:
  • Financial reporting is conducted in USD (United States Dollar) and shares.

This summary captures the essential elements and updates from the Amendment No. 1 filing, highlighting the company's identification, the nature of the filing, changes made, and the context of the financial reporting.